PropertyValue
?:abstract
  • The current COVID‐19 pandemic has a tremendous impact on daily life world‐wide. Despite the ability to dampen the spread of SARS‐CoV‐2, the causative agent of the diseases, through restrictive interventions, it is believed that only effective vaccines will provide sufficient control over the disease and revert societal live back to normal. At present, a double‐digit number of efforts are devoted to the development of a vaccine against COVID‐19. Here, we provide an overview of these (pre)clinical efforts and provide background information on the technologies behind these vaccines. In addition, we discuss potential hurdles that need to be addressed prior to mass scale clinical translation of successful vaccine candidates.
?:creator
?:doi
?:doi
  • 10.1002/anie.202008319
?:journal
  • Angew_Chem_Int_Ed_Engl
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/1a85da594231a9b2c2b107307864c16b37db6dc7.json
?:pmcid
?:pmid
?:pmid
  • 32663348.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • Current status of COVID‐19 (pre)clinical vaccine development
?:type
?:year
  • 2020-07-14

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/a10mgxtj>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/a10mgxtj>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all